• Info
  • Insider Ownership

Insider Trading & Ownership of Timothy P. Clackson

Location
Cambridge, MA
Summary
The estimated net worth of Timothy P. Clackson is at least $214,649 dollars as of 24 Jul 2025. Timothy P. Clackson is the President and CEO, Director of Theseus Pharmaceuticals, Inc. and owns shares of Theseus Pharmaceuticals, Inc. stock worth about $139.2K. Timothy P. Clackson is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $75.5K.
Signature
/s/ Robert Yang, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Timothy P. Clackson and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Timothy P. Clackson has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $214,649.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Theseus Pharmaceuticals, Inc. ($139,156).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Timothy P. Clackson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
THRX Theseus Pharmaceuticals, Inc. President and CEO, Director $139,156 01 Mar 2023
XLO Xilio Therapeutics, Inc. 10%+ Owner $75,493 21 Oct 2021
ELEV Elevation Oncology, Inc. Director $0 23 Jul 2025
FMTX Forma Therapeutics Holdings, Inc. Director 14 Oct 2022

Insider Transactions Reported by Timothy P. Clackson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.